Furthermore, several other proteomic studies have identified afamin as a potential biomarker in other disorders, including simian immunodeficiency virus (SIV) induced central nervous system disease [10], ovarian cancer [65], congenital disorders of glycosylation [66] and Down syndrome [67]. The gene discussed is AFM; the disease is congenital disorder of glycosylation.